Ledger.Open graph →
SEC Form D · filed September 1, 2020

LB PHARMACEUTICALS INC

Offering
$10.0M
Sold
$4.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Piero Poli · New York, NYDirectorEdmund Sullivan · New York, NYDirectorZachary Prensky · New York, NYExec · DirectorRobert Ruffolo · New York, NYDirectorVincent Grattan · New York, NYDirectorMarc Panoff · New York, NYExecRichard Boyle · Boston, MADirectorScjp, Ltd · GRAND CAYMAN, Cayman IslandsDirectorChris Cheever · Boston, MADirectorVincenzo O. Laruffa · New York, NYExecRei Goffer · Boston, MAExec · DirectorMPG Asset Management, LLC · Murphy, TXDirectorJohn F. Arrillaga Jr · New York, NYExec · DirectorWendy F. Abels Eisenberg · New York, NYDirectorDouglas F. Eisenberg · New York, NYDirectorLynne L. Segall · Beverly Hills, CAExecKeaton Cristobal · Garrison, NYDirectorAndrew Chomer · Garrison, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗